Trials / Completed
CompletedNCT01502813
Citicoline, Creatine, and Omega-3 Effects in Middle Age Women
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Deborah Yurgelun-Todd · Academic / Other
- Sex
- Female
- Age
- 40 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine the functional effects of a citicoline, creatine, and omega-3 fatty acids combination when administered for a duration of four weeks (28 days) to non-psychiatric adult female participants.
Detailed description
Standard clinical measures for mood and neuropsychological measures of attention, cognitive inhibition and memory will be applied before, during, and after a course of a daily supplementation of citicoline, creatine and omega-3 for 28 days to non-psychiatric adult female participants. We hypothesis that the combination of supplements will improve memory and attention in healthy adult women.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Citicoline, Omega-3 Fatty Acids and Creatine | Citicoline: 500 mg/day for 28 days Omega-3 Fatty Acids: 2 g/day for 28 days Creatine: 5 g/day for 28 days |
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2018-10-30
- Completion
- 2019-11-01
- First posted
- 2012-01-02
- Last updated
- 2021-04-22
- Results posted
- 2021-04-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01502813. Inclusion in this directory is not an endorsement.